Sajid Asghar
About
In The Last Decade
Sajid Asghar
98 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 125
- Biomaterials 901
- Molecular Biology 730
- Pharmaceutical Science 691
- Biomedical Engineering 496
- Molecular Medicine 395
Countries citing papers authored by Sajid Asghar
This map shows the geographic impact of Sajid Asghar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sajid Asghar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sajid Asghar more than expected).
Fields of papers citing papers by Sajid Asghar
This network shows the impact of papers produced by Sajid Asghar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sajid Asghar. The network helps show where Sajid Asghar may publish in the future.
Co-authorship network of co-authors of Sajid Asghar
This figure shows the co-authorship network connecting the top 25 collaborators of Sajid Asghar. A scholar is included among the top collaborators of Sajid Asghar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sajid Asghar. Sajid Asghar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 0 | |
| 7 | 6 | |
| 8 | 14 | |
| 9 | 4 | |
| 10 | 83 | |
| 11 | 17 | |
| 12 | 12 | |
| 13 | 18 | |
| 14 | 19 | |
| 15 | 10 | |
| 16 | 30 | |
| 17 | Development and validation of a stability-Indicating RP-HPLC method for simultaneous estimation of sofosbuvir and velpatasvir in fixed dose combination tablets and plasma. | 7 |
| 18 | 50 | |
| 19 | 30 | |
| 20 | 141 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.